Impact of Reduced Vancomycin MIC on Clinical Outcomes of Methicillin-Resistant Staphylococcus aureus Bacteremia

Vancomycin has been a key antibiotic agent for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections. However, little is known about the relationship between vancomycin MIC values at the higher end of the susceptibility range and clinical outcomes. The aim of this study was...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Park, So-Youn, Oh, In-Hwan, Lee, Hee-Joo, Ihm, Chun-Gyoo, Son, Jun Seong, Lee, Mi Suk, Kim, Mi-Na
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2013
Assuntos:
Susceptibility
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3811271/
https://ncbi.nlm.nih.gov/pubmed/23979741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01137-13
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados